General Moly, Inc.
GMO
GMO was delisted on the 30th of September, 2020.
64 hedge funds and large institutions have $39.6M invested in General Moly, Inc. in 2013 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 33 reducing their positions, and 7 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 67 → 64 (-3)
10% less capital invested
Capital invested by funds: $44.2M → $39.6M (-$4.63M)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
52% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 33
70% less call options, than puts
Call options by funds: $11K | Put options by funds: $37K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VanEck Associates
New York
|
+$770K |
| 2 |
CC
Cannell Capital
Alta,
Wyoming
|
+$588K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$288K |
| 4 |
SCM
Sterneck Capital Management
Kansas City,
Missouri
|
+$238K |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
+$59.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$168K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$164K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$149K |
| 4 |
LMF
LMR Master Fund
Grand Cayman,
Cayman Islands
|
-$125K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$98K |
GMO Hedge Fund Activity: Q3 2013 in Review
64 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in General Moly, Inc. (GMO) for Q3 2013, worth a combined $39.6M — down 10% from $44.2M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of GMO and 4 opened new positions — a net loss of 3 holders — while 33 trimmed existing stakes and 16 added.
The largest buyer was VanEck Associates, adding an estimated $770K. The largest seller was Morgan Stanley, cutting an estimated $168K.
- 64 institutional investors held General Moly, Inc. (GMO) as of Q3 2013, down from 67 in Q2 2013.
- Funds reported $39.6M of General Moly, Inc. stock for Q3 2013, down 10% quarter-over-quarter.
- 4 funds opened new General Moly, Inc. positions in Q3 2013 and 7 closed out, a net change of -3 holders.
- The largest General Moly, Inc. buyer in Q3 2013 was VanEck Associates, an estimated $770K added.
- The largest General Moly, Inc. seller in Q3 2013 was Morgan Stanley, an estimated $168K sold.
Based on aggregated 13F filings for Q3 2013.